Bladder Cancer - Biomarker signature test can predict tumor response to bladder cancer immunotherapy
Can't see this email? View it online
   
  Bladder Cancer Bladder Cancer logo  
  The latest bladder cancer news from News Medical  
 
bladder Discovery of new biomarkers could lead to early detection of bladder cancer
 
A University of Houston biomedical engineer and his team are reporting the discovery of new biomarkers for early detection of bladder cancer (BC), among the most common cancers diagnosed in men in the U.S. According to the American Cancer Society
 
 
   Biomarker signature test can predict tumor response to bladder cancer immunotherapyBiomarker signature test can predict tumor response to bladder cancer immunotherapy
 
In a discovery that could improve the survival of bladder cancer patients, Northwestern Medicine scientists have developed a biomarker signature test to predict which tumors will respond to immunotherapy.
 
   New Genetic Mutations Linked to Canine Bladder Cancers IdentifiedNew Genetic Mutations Linked to Canine Bladder Cancers Identified
 
Researchers have identified new genetic mutations linked to a subset of canine bladder cancers. Their findings have implications both for early cancer detection and for targeted treatments in dogs and humans.
 
   New technology allows urologists to identify and remove bladder tumors more easilyNew technology allows urologists to identify and remove bladder tumors more easily
 
UC San Diego Health is the first health system in San Diego County to offer a new technology that detects and monitors bladder cancer in both the clinic and operating room settings by using blue light, white light and an imaging dye that makes cancer cells glow florescent pink.
 
   Inexpensive combo-chemotherapy found to be better tolerated than BCG for common bladder cancerInexpensive combo-chemotherapy found to be better tolerated than BCG for common bladder cancer
 
An on-going, worldwide shortage of bacillus Calmette-Guérin (BCG) means that many patients with a common and serious type of bladder cancer have limited access to this effective standard of care treatment.